
The average Dana-Farber Cancer Institute Investor Relations earns an estimated $83,115 annually. Dana-Farber Cancer Institute's Investor Relations compensation is $1,185 more than the US average for a Investor Relations.
Last updated 7 months ago.
The majority of Investor Relations at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Investor Relations at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute